.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Understanding cellular heterogeneity is vital for modern clinical research. A revolutionary single-cell metabolomics platform known as Hybrid-CytoMS has emerged to address existing limitations in metabolite coverage. Traditional methods often struggle with low intracellular abundance and diverse physicochemical properties of metabolites. However, this new technology integrates a dielectric barrier discharge ionization (DBDI) source with an electrospray ionization (ESI)-based system. Consequently, the integration significantly enhances ionization efficiency through the synergistic complementarity of both mechanisms.
The platform utilizes a coaxial architecture to minimize ion transmission losses during high-throughput analysis. Specifically, the system maintains a rate of 30 cells per minute, allowing for rapid data collection. In positive ion mode, researchers detected over 2,500 features and 369 annotated metabolites. This represents a substantial increase compared to conventional ESI-only methods. Furthermore, the Hybrid-CytoMS enables the detection of nonpolar compounds that were previously invisible, providing a more comprehensive metabolic picture.
The practical application of this single-cell metabolomics platform was demonstrated in a study involving benzo[a]pyrene (BaP) exposure. BaP is a well-known polycyclic aromatic hydrocarbon and a prototypical carcinogen. Researchers applied Hybrid-CytoMS to HepG2 liver cancer cells to resolve metabolic perturbations at single-cell resolution. Specifically, the team successfully characterized the uptake and clearance curves of intracellular BaP. These findings help clarify the dynamic relationship between exogenous exposure and endogenous metabolic status.
Moreover, the study successfully tracked the metabolic trajectory across exposure time. This level of detail allows clinicians to understand how individual cells respond to toxic stress. Such insights are crucial for developing targeted therapies and understanding drug resistance in oncology. The high-throughput nature of the platform ensures that large cell populations can be analyzed efficiently, improving the statistical power of metabolic studies.
This technology paves the way for deeper investigations into cellular metabolic heterogeneity. By providing high-coverage data, Hybrid-CytoMS helps identify rare cell populations that may drive disease progression. Clinicians can potentially use these metabolic signatures to monitor therapeutic efficacy or environmental toxicity. As single-cell technologies continue to evolve, they will likely become integral to personalized medicine strategies in India and globally.
Hybrid-CytoMS combines DBDI and ESI ionization mechanisms. This dual-source approach allows for the simultaneous detection of polar, moderately polar, and nonpolar compounds, which conventional single-source systems often miss.
BaP is a potent carcinogen found in environmental pollutants. Studying its metabolic effects on HepG2 (liver) cells at the single-cell level helps researchers understand the mechanisms of chemical-induced liver injury and carcinogenesis.
The platform achieves a throughput of 30 cells per minute while maintaining high sensitivity and minimal ion loss due to its unique coaxial architecture.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional recommendation. Refer to the latest local and national guidelines for clinical practice.
References
Zhang Y et al. Coaxial Hybrid Ionization-Mass Cytometry for High-Throughput and High-Coverage Single-Cell Metabolomics. Anal Chem. 2026 Jun 18. doi: 10.1021/acs.analchem.6c02532. PMID: 42312475.
Luo M, Kou T, Yin Y, et al. Deep-coverage single-cell metabolomics enabled by ion mobility-resolved mass cytometry. Nature Methods. 2026;23(4):585-595.
Xu T, Li H, Dou P, et al. Concentric Hybrid Nanoelectrospray Ionization-Atmospheric Pressure Chemical Ionization Source for High-Coverage Mass Spectrometry Analysis of Single-Cell Metabolomics. Adv Sci. 2024;11(2):2306659.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Researchers have developed Hybrid-CytoMS, a coaxial hybrid ionization-mass cytometry platform that integrates DBDI and ESI sources. This system significantly improves metabolite coverage and throughput, enabling detailed single-cell metabolic profiling for advanced oncology and toxicology studies.
2 months ago
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
Last week
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
4 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
Last week
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
4 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
Last week
